Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Menu

ANI Pharma Inc (ANIP)

ANI Pharma Inc (ANIP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
FATE Q3 Earnings Beat on Higher Revenues, Pipeline in Focus
FATE Q3 Earnings Beat on Higher Revenues, Pipeline in Focus Zacks Investment Research - Wed Nov 13, 11:26AM CST

Fate Therapeutics FATE reported a loss of 40 cents per share in the third quarter of 2024, narrower than the Zacks Consensus Estimate of a loss of 42 cents. The company reported a loss of 46 cents per...

IMCR : 32.42 (-0.43%)
CSTL : 28.45 (-1.45%)
ANIP : 54.30 (-1.45%)
FATE : 2.23 (+0.45%)
Axsome's Q3 Earnings Beat, Auvelity Drives Sales Growth, Stock Up
Axsome's Q3 Earnings Beat, Auvelity Drives Sales Growth, Stock Up Zacks Investment Research - Wed Nov 13, 11:10AM CST

Axsome Therapeutics, Inc. AXSM incurred an adjusted loss of $1.34 per share in the third quarter of 2024, narrower than the Zacks Consensus Estimate of a loss of $1.38. The company had incurred a loss...

JAZZ : 122.00 (+2.31%)
CSTL : 28.45 (-1.45%)
ANIP : 54.30 (-1.45%)
AXSM : 95.71 (+1.18%)
SpringWorks' Q3 Loss Narrower Than Expected, Revenues Miss Mark
SpringWorks' Q3 Loss Narrower Than Expected, Revenues Miss Mark Zacks Investment Research - Wed Nov 13, 10:54AM CST

SpringWorks Therapeutics, Inc. SWTX incurred a loss of 72 cents per share in the third quarter of 2024, which was narrower than the Zacks Consensus Estimate of a loss of 76 cents. The company had reported...

IMCR : 32.42 (-0.43%)
CSTL : 28.45 (-1.45%)
ANIP : 54.30 (-1.45%)
SWTX : 37.44 (-1.29%)
Mirum's Q3 Earnings Beat Estimates, 2024 Revenue View Raised
Mirum's Q3 Earnings Beat Estimates, 2024 Revenue View Raised Zacks Investment Research - Tue Nov 12, 11:54AM CST

Mirum Pharmaceuticals, Inc. MIRM incurred a loss of 30 cents per share in third-quarter 2024, much narrower than the Zacks Consensus Estimate of a loss of 45 cents. The company had reported a loss of 57...

IMCR : 32.42 (-0.43%)
MIRM : 43.69 (+3.80%)
CSTL : 28.45 (-1.45%)
ANIP : 54.30 (-1.45%)
ANI: Q3 Earnings Snapshot AP - Fri Nov 8, 5:58AM CST

ANI: Q3 Earnings Snapshot

ANIP : 54.30 (-1.45%)
ANI Pharmaceuticals Reports Record Third Quarter 2024 Financial Results and Raises 2024 Guidance GlobeNewswire - Fri Nov 8, 5:50AM CST

ANIP : 54.30 (-1.45%)
ANI Pharmaceuticals to Present at Guggenheim's Inaugural Healthcare Innovation Conference and Jefferies London Healthcare Conference in November GlobeNewswire - Mon Nov 4, 3:30PM CST

ANIP : 54.30 (-1.45%)
ANI Pharmaceuticals to Discuss Third Quarter 2024 Financial Results on November 8, 2024, at 8:00 a.m. ET GlobeNewswire - Wed Oct 30, 4:00PM CDT

ANIP : 54.30 (-1.45%)
ANI Pharmaceuticals Announces the FDA Approval and Launch of Estradiol Gel, 0.06% GlobeNewswire - Fri Oct 25, 5:50AM CDT

ANIP : 54.30 (-1.45%)
ANI Pharmaceuticals to Present New Data Highlighting Membranous Nephropathy Research at American Society of Nephrology Kidney Week 2024 GlobeNewswire - Thu Oct 24, 5:50AM CDT

ANIP : 54.30 (-1.45%)

Barchart Exclusives

Nvidia Stock: Why Any Pullback is a Buying Opportunity Barchart - 6 minutes ago
Nvidia’s outlook for Q4 revenue came in slightly below analysts' forecasts and its margins are under pressure, prompting a modest dip 2.5% in after-hours trading. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot